Image1_Network Meta-Analysis on the Effects of SGLT2 Inhibitors Versus Finerenone on Cardiorenal Outcomes in Patients With Type 2 Diabetes and Chronic.PNG (7.22 kB)
Image1_Network Meta-Analysis on the Effects of SGLT2 Inhibitors Versus Finerenone on Cardiorenal Outcomes in Patients With Type 2 Diabetes and Chronic Kidney Disease.PNG
figure
posted on 2022-01-24, 04:46 authored by Li-Min Zhao, Ze-Lin Zhan, Jie Ning, Mei QiuThe full text of this article can be freely accessed on the publisher's website.
